Continuous hemofiltration in 2009: What is new for clinicians regarding pathophysiology, preferred technique and recommended dose?

Blood Purification

Volumn 28, Issue 2, 2009, Pages 135-143

  Honore P M ^a   Joannes Boyau, O ^b   Collin, V ^c   Boer, W ^d   Jennes, S ^a  

^a QUEEN ASTRID MILITARY HOSPITAL   (Belgium)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c Clinique Europe St Michel   (Belgium)

^d Zuyderland Medical Centre   (Netherlands)

Author keywords

Acute kidney injury; Continuous renal replacement therapy; Dialysis; Hemofiltration, high volume; Mediator removal; Sepsis

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ACUTE PANCREATITIS; CHAOS THEORY; CLINICAL PRACTICE; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONVALESCENCE; DILUTION; HEMODIALYSIS; HUMAN; IMMUNOMODULATION; INTENSIVE CARE UNIT; PATHOPHYSIOLOGY; PHYSICIAN; POROSITY; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT INDICATION; ULTRAFILTRATION;

CLINICAL PROTOCOLS; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; POINT-OF-CARE SYSTEMS; SEPSIS;

EID: 67649840650     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227282     Document Type: Review

References (61)

1. Ronco C, Bellomo R, Homel P, et al: effects of different doses in continuous veno-venous haemofiltration. Lancet 2000;356:26-30.
2. Saudan P, Niederberger M, De Seigneux S, et al: Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006;70:1312-1317. (Pubitemid 44435183)
3. Palevsky PM, Zhang JH, O'Connor TZ, et al: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359:7-20. (Pubitemid 351931092)
4. Metnitz PG, Krenn CG, Steltzer H, et al: Effects of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002;30:2051-2058.
5. Mehta RL, McDonald B, Gabbai FB, et al; Collaborative Group for Treatment of ARF in the ICU: A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001;60:1154-1163.
6. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-150.
7. Ronco C, Bellomo R: Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 2002;25:733-747.
8. Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bellomo R: Interpreting the mechanism of continuous renal replacement therapy in sepsis. The peak concentration hypothesis. Artif Organs 2003;27:792-801.
9. Ronco C, Ricci Z, Bellomo R: Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role for CVVH. EDTNA ERCA J 2002;(suppl 2):13-18. (Pubitemid 35051499)
10. Honoré PM, Joannes-Boyau O, Boer W, Gressens B: High volume haemofiltration and hybrid techniques in sepsis: new insights into the rationale. Neth J Crit Care 2007;11:239-242.
11. Honoré PM, Joannes-Boyau O, Gressens B: Blood and plasma treatments: the rationale of high-volume hemofiltration; in Ronco C, Bellomo R, Kellum JA (eds): Acute Kidney Injury. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 387-395.
12. Di Carlo JV, Alexander SR: Hemofiltration for cytokine-driven illness: the mediator delivery hypothesis. Int J Artif Organs 2005;28:777-786.
13. Olszewski WL: The lymphatic system in body homeostasis: physiological conditions. Lymphat Res Biol 2003;1:11-24.
14. Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Beraud JJ: Continuous venovenous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNF-α and IL-6 plasma concentrations. J Nephrol 2002;15:150-157. (Pubitemid 34594165)
15. Seely AJ, Christou NV: Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 2000;28:2193-2200.
16. Mayer J, Rau B, Gansauge F, Beger HG: Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000;47:542-552.
17. Ertel W, Kremer JP, Kenney J, et al: Down regulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995;85:1341-1347.
18. Honoré PM, Joannes-Boyau O, Merson L, et al: The big bang of hemofiltration: the beginning of a new era in the third millennium for extra-corporeal blood purification! Int J Artif Organs 2006;29:649-659.
19. Valbonesi M, Carlier P, Icone A, et al: Cascade filtration: a new filter for secondary filtration - a multicentric study. Int J Artif Organs 2004;27:513-515. (Pubitemid 39345357)
20. Joannes-Boyau O, Honoré PM, Boer W: Hemofiltration: the case for removal of sepsis mediators from where they do harm. Crit Care Med 2006;34:2244-2246. (Pubitemid 44305640)
21. Matson JR, Zydney RL, Honoré PM: Blood filtration: new opportunities and the implications on system biology. Crit Care Resusc 2004;6:209-218.
22. Bellomo R, Tetta C, Ronco C: Coupled plasma filtration adsorption. Intensive Care Med 2003;29:1222-1228.
23. Honoré PM, Matson JR: Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design. Crit Care 2002;6:394-396.
24. Honoré PM, Joannes-Boyau O: 'The French Hemodiafe Trial': this study is neither decisive nor definitive in resolving the controversy on renal replacement therapy in ICU. Int J Artif Organs 2006;29:1190-1192.
25. Bellomo R, Honoré PM, Matson JR, Ronco C, Winchester J: Extracorporeal blood treatment (EBT) methods in SIRS/sepsis. Int J Artif Organs 2005;28:450-458. (Pubitemid 40823645)
26. Bouman CSC, Oudemans-van-Straaten HM: Guidelines for timing, dose, and mode of continuous replacement therapy for acute renal failure in the critically ill. Neth J Crit Care 2006;10:561-568.
27. Honoré PM, Joannes-Boyau O, Gressens B: Blood and plasma treatments: high-volume hemofiltration - a global view; in Ronco C, Bellomo R, Kellum JA (eds): Acute Kidney Injury. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 371-386.
28. Bellomo R, Ronco C, Kellum J, Mehta R, Palevsky P; the ADQI Workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-R212.
29. Joannes-Boyau O, Honoré PM: The IVOIRE study. Available at: www.clinicaltrials.gov/ct/show/NCT00241228 (accessed January 2008).
30. Bouman CS, Oudemans-Van-Straaten HM, Tijssen JG, Zandstra DF, Kosecioglu J: Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002;30:2205-2211.
31. Jiang HL, Xhue WJ, Li DK, et al: Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 2005;11:4815-4821.
32. Laurent I, Adrie C, Vinsonneau C, et al: High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005;46:432-437. (Pubitemid 41040282)
33. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF: Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 1999;25:814-821.
34. Piccinni P, Dan M, Barbacini S, et al: Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006;32:80-86. (Pubitemid 43039380)
35. Honoré PM, Jamez J, Wauthier M, et al: Prospective evaluation of short-term high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28:3581-3587. (Pubitemid 30948994)
36. Honoré PM, Joannes-Boyau O, Merson L, Fleureau C, Roze H, Janvier G: Pulse high volume hemofiltration in septic shock plus acute renal failure (PULSHAR Study). Blood Purif 2006;24:267-268.
37. Cornejo R, Downey P, Castro R, et al: High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 2006;32:713-722.
38. Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G: Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 2004;50:102-109. (Pubitemid 38064009)
39. Grootendorst AF, van Bommel EF, van der Hoeven B, van Leengoed LA, van Osta AL: High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992;18:235-240.
40. Grootendorst AF, van Bommel EF, van Leengoed LA, Nabuurs M, Bouman CS, Groeneveld AB: High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 1994;2:72-78.
41. Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL: Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 1999;27:1848-1855. (Pubitemid 29455115)
42. Honoré PM, Zydney AL, Matson JR: High volume and high permeability haemofiltration in sepsis. The evidences and the key issues. Care Crit Ill 2003;3:69-76.
43. Journois D, Israel-Biet D, Pouard P, et al: High volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 1996;85:965-976. (Pubitemid 26378280)
44. Honoré PM, Joannes-Boyau O: High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 2004;27:1077-1082.
45. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P: High-volume haemofiltration in human septic shock. Intensive Care Med 2001;27:978-986. (Pubitemid 32662478)
46. Ratanarat R, Brendolan A, Piccinni P, et al: Pulse-high volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 2005;9:294-302.
47. Wang H, Zhang ZH, Yan XW, et al: Amelioration of haemodynamics and oxygen metabolism by continuous veno-venous hemofiltration in experimental pancreatitis. Word J Gastroenterol 2005;11:127-131. (Pubitemid 40090150)
48. Wang H, Li WQ, Zhou W, Li N, Li JS: Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol 2003;9:2096-2099. (Pubitemid 37168451)
49. Ronco C, Honoré PM: Comments regarding the VA/NIH study. N Engl J Med 2008;359:1959-1962.
50. Ronco C, Cruz D, Oudemans-van-Straaten HM, Honoré PM, House A, Bin D, Gibney N: Dialysis dose in acute kidney injury: no time for therapeutic nihilism - a critical appraisal of the Acute Renal Failure Trial Network study. Crit Care 2008;12:308.
51. ANZICS Clinical Trials Group: Augmented vs. normal renal replacement therapy in severe acute renal failure (ARF) (renal study). Clinical trials.gov/ct2/show/NCT00221013 (accessed January 2009).
52. Li CM, Chen JH, Zhang P, et al: Continuous veno-venous haemofiltration attenuates myocardial mitochondrial respiratory chain complexes activity in porcine septic shock. Anaesth Intensive Care 2007;35:911-919. (Pubitemid 350248091)
53. Mandolfo S, Galli F, Costa S, Ravani P, Gaggia P, Imbasciati E: Factors influencing permanent catheter performance. J Vasc Access 2001;2:106-109. (Pubitemid 32936758)
54. Ricci Z, Ronco C: Pre- versus post-dilution CVVH. Blood Purif 2005;23:338-342.
55. Nurmohamed SA, Vervloet MG, Girbes AR, Ter Wee PM, Groeneveld AB: Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study. Blood Purif 2007;25:316-323.
56. Ratanarat R, Cazzavillan S, Ricci Z, et al: Usefulness of a molecular strategy for the detection of bacterial DNA in patients with severe sepsis undergoing continuous renal replacement therapy. Blood Purif 2007;25:106-111. (Pubitemid 46005760)
57. Arzuaga A, Isla A, Gascon AR, Maynar J, Corral E, Pedraz JL: Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters: evaluation of the sieving coefficient. Blood Purif 2006;24:347-354. (Pubitemid 44215178)
58. Kooman JP, van der Sande FM, Beerenhout CM, Leunissen KM: On-line filtration therapies: emerging horizons. Blood Purif 2006;24:159-162.
59. Bellomo R, Kellum JA, Mehta R, Ronco C: The Acute Dialysis Quality Initiative II: the Vicenza conference. Adv Ren Replace Ther 2002;9:290-293. (Pubitemid 35253320)
60. Tetta C, Bellomo R, Kellum J, et al: High volume hemofiltration in critically ill patients: why, when and how?; in Ronco C, Bellomo R, Brendolan A (eds): Sepsis, Kidney and Multiple Organ Dysfunction. Contrib Nephrol. Basel, Karger, 2004, vol 144, pp 362-375.
61. Honoré PM, Joannes-Boyau O, Boer W, Collin V: High-volume hemofiltration in sepsis and SIRS: current concepts and future prospects. Blood Purif 2009;28:1-11.